Seoul, South Korea

Jeongjun Kim

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 14.5

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jeongjun Kim: An Innovator in Pharmaceutical Development

Introduction

Jeongjun Kim is a notable inventor based in Seoul, South Korea, recognized for his contributions to pharmaceutical innovations. With a total of three patents to his name, he has been actively involved in the development of novel compounds that have promising applications in treating various diseases.

Latest Patents

One of Jeongjun's latest patents involves the development of 2-amino-benzimidazole derivatives, which serve as inhibitors of 5-lipoxygenase and/or prostaglandin E synthase. This invention focuses on compounds characterized by a specific general formula, allowing for various substitutions that enhance their efficacy in treating inflammatory diseases, cancer, stroke, and Alzheimer's disease.

Another significant patent by Jeongjun is centered around quinoline derivatives as TAM receptor tyrosine kinase (RTK) inhibitors. This invention introduces novel compounds that inhibit the TAM family members (Axl, Mer, and Tyro 3) and Met RTKs, which can be essential in addressing hyperproliferative disorders including immune-suppressive cancers and metastatic disease.

Career Highlights

Throughout his career, Jeongjun Kim has contributed to the field through his work with prominent organizations such as Qurient Co., Ltd. and Institut Pasteur Korea. His efforts in pharmaceutical research have positioned him as a key figure in the development of innovative treatments for serious health conditions.

Collaborations

In addition to his individual efforts, Jeongjun has collaborated with fellow researchers and colleagues, including Jaeseung Kim and Kiyean Nam. These collaborations have amplified his impact in the industry and fostered a collaborative environment for advancing pharmaceutical sciences.

Conclusion

Jeongjun Kim exemplifies the spirit of innovation in the pharmaceutical field. With his pioneering patents and collaborative efforts, he continues to lay the groundwork for advancements in medicine aimed at improving the quality of life for patients afflicted with critical diseases. His work not only showcases individual brilliance but also highlights the importance of teamwork and collaboration in achieving significant scientific milestones.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…